These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 720740)

  • 41. Management of essential hypertension with oxprenolol and chlorthalidone in a fixed combination.
    Karachalios GN
    Int J Clin Pharmacol Res; 1983; 3(3):153-6. PubMed ID: 6679518
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyperkalaemia and overdose of antihypertensive agents.
    Hume L; Forfar JC
    Lancet; 1977 Dec; 2(8049):1182. PubMed ID: 73096
    [No Abstract]   [Full Text] [Related]  

  • 43. [Combination therapy of arterial hypertension].
    von Manteuffel GE; Ebel H; Zehner J
    Med Klin; 1980 Apr; 75(8):297-302. PubMed ID: 6104777
    [No Abstract]   [Full Text] [Related]  

  • 44. Hyperkalaemia and overdose of antihypertensive agents.
    Nawar T
    Lancet; 1978 Apr; 1(8066):717. PubMed ID: 76255
    [No Abstract]   [Full Text] [Related]  

  • 45. A study comparing indapamide with cyclopenthiazide in geriatric patients.
    Khan AU
    Postgrad Med J; 1981; 57 Suppl 2():42-3. PubMed ID: 7033945
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Captopril and oxprenolol in a fixed combination with thiazide diuretics: comparison of their antihypertensive efficacy and metabolic effects.
    Costa FV; Borghi C; Ambrosioni E
    Clin Ther; 1984; 6(5):708-18. PubMed ID: 6383615
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical trial of a combination preparation of clonidine and cyclothiazide (author's transl)].
    Wimmer PP
    MMW Munch Med Wochenschr; 1977 Aug; 119(34):1085-8. PubMed ID: 408656
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A multicenter clinical comparison study between Tevacor and Trasicor in hypertension].
    Shmueli H; Rosenfeld J
    Harefuah; 1986 Jun; 110(11):550-2. PubMed ID: 3533738
    [No Abstract]   [Full Text] [Related]  

  • 49. Prazosin alone and combined with a thiazide diuretic in the treatment of hypertension.
    Seedat YK; Seedat MA; Bhoola R
    S Afr Med J; 1977 Apr; 51(14):461-3. PubMed ID: 860171
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of a slow release formulation of oxprenolol with conventional oxprenolol in the treatment of hypertension.
    O'Brien KP; Stephens EJ
    N Z Med J; 1976 Aug; 84(570):142-4. PubMed ID: 1069924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Importance of a fixed combination of AT1-receptor blockade and hydrochlorothiazide for blood pressure lowering in cardiac risk patients. A postmarketing surveillance study with candesartan/HCTZ].
    Bramlage P; Schönrock E; Odoj P; Wolf WP; Funken C
    MMW Fortschr Med; 2008 Feb; 150(6):40. PubMed ID: 18323344
    [No Abstract]   [Full Text] [Related]  

  • 52. Once daily administration of a beta-blocker in hypertension.
    Watt M; Duncan TD
    N Z Med J; 1978 Feb; 87(606):126-8. PubMed ID: 274648
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and hemodynamic effects of high doses of slow release furosemide in arterial hypertension. A double-blind cross-over study with cyclopenthiazide.
    Krogsgaard AR; Trap-Jensen J; Hartling O; Svendsen TL
    Acta Med Scand Suppl; 1976; 602():110-3. PubMed ID: 800315
    [No Abstract]   [Full Text] [Related]  

  • 54. [Merit and demerit of fixed dose combination therapy between ARB and diuretics in hypertension].
    Kimura G
    Nihon Rinsho; 2011 Nov; 69(11):2051-8. PubMed ID: 22111329
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Continuous 24-hour registration of intra-arterial pressure in basal states and during therapy with a fixed slow-release oxprenolol-chlorthalidone combination, administered once a day].
    Fariello R; Alicandri C; Boni E; Montini E; Zaninelli A; Agabiti-Rosei E; Motolese M; Muiesan G
    G Ital Cardiol; 1984 Feb; 14(2):121-6. PubMed ID: 6714549
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Experience in the ambulatory treatment of primary arterial hypertension with a fixed oxprenolol-chlorthalidone combination].
    Zampaglione G; Ferrari O; Bianchi C; Bonifazi C; Coppetti S; Costanza G; Lanzarini L; Ricevuti A; Rinaldo R; Rizzi GM; Tavecchi L; Ziletti G; Distante S
    G Clin Med; 1980 Oct; 61(10):776-88. PubMed ID: 7239053
    [No Abstract]   [Full Text] [Related]  

  • 57. A multicentre evaluation of sustained release oxprenolol in the management of hypertension in hospital out-patient practice.
    Forrest WA
    J Int Med Res; 1978; 6(2):136-40. PubMed ID: 631415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oxprenolol in hypertension: a report on 2,770 patients in general practice originally treated with methyldopa.
    Forrest WA
    Scott Med J; 1976 Jan; 21(1):28-30. PubMed ID: 1257736
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of oxprenolol plus chlorthalidone in fixed combination against chlorthalidone alone in mild to moderate essential hypertension; a clinical trial.
    Gruppillo P; Tomasi AM; Masoni A; Finzi C
    G Ital Cardiol; 1980; 10(4):476-9. PubMed ID: 7002694
    [No Abstract]   [Full Text] [Related]  

  • 60. Fixed dose combination therapy in the treatment of hypertension.
    Stanton T; Reid JL
    J Hum Hypertens; 2002 Feb; 16(2):75-8. PubMed ID: 11850763
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.